Provided by Tiger Trade Technology Pte. Ltd.

Nasdaq

99.47
+0.74000.75%
Pre-market: 99.480.0117+0.01%05:35 EDT
Volume:1.54M
Turnover:153.28M
Market Cap:55.60B
PE:29.01
High:99.67
Open:98.43
Low:98.26
Close:98.73
52wk High:101.79
52wk Low:76.55
Shares:559.00M
Float Shares:496.00M
Volume Ratio:0.49
T/O Rate:0.31%
Dividend:1.12
Dividend Rate:1.13%
EPS(TTM):3.43
EPS(LYR):3.09
ROE:16.52%
ROA:5.85%
PB:4.64
PE(LYR):32.19

Loading ...

Ascendis Pharma Q2 FY26 Swings to Net Profit of €207 Million; Revenue More than Doubles to €339 Million

Reuters
·
Aug 13

SalesCloser Wins Third US Patent for In-Conversation AI Appointment Booking

Reuters
·
Aug 13

MediPharm Labs Swings to Q2 FY26 Profit; Revenue Rises 11% to $10 Million vs Q1 FY26

Reuters
·
Aug 13

Indonesia Energy Drills K-29 Well Past 2,500 Feet, Targets 3,400-Foot Total Depth

Reuters
·
Aug 13

Liminatus Pharma Moves NASDAQ Listing to Capital Market Tier

Reuters
·
Aug 13

Pelthos Q2 FY26 Net Loss Narrows to $23.42 Million; Net Product Revenue Climbs 45% to $15.4 Million

Reuters
·
Aug 13

Calian Q3 FY26 Adjusted Ebitda Climbs 35% to C$26 Million; Revenue Rises 20% to C$230 Million

Reuters
·
Aug 13

Sagimet Wins FDA IND Clearance for Phase 3 Denifanstat Acne Trial

Reuters
·
Aug 13

Victoria’s Secret Sets Second-Quarter Earnings Call Webcast

Reuters
·
Aug 13

Profusa to Execute 1-for-4 Reverse Stock Split Aug. 17

Reuters
·
Aug 13

Palomino Labs to Join Needham Virtual Semiconductor & SemiCap Conference

Reuters
·
Aug 13

YXT.com 1H FY26 Net Loss Narrows 80.5% to RMB 14.4 Million; Revenue Rises 6% to RMB 162.1 Million

Reuters
·
Aug 13

Unisync FY26 Q3 Net Income Rises to $1.5 Million; Revenue Increases 8.1% to $23.6 Million

Reuters
·
Aug 13

Zenas BioPharma Q2 FY26 Net Loss Widens to $111.5 Million; Revenue Rises to $1 Million

Reuters
·
Aug 13

Xali Gold Targets Late-September Start for 3,000-Meter Drill Program at Pico Machay Project in Peru

Reuters
·
Aug 13

Lantronix to Report Fiscal Q4 Results After Market Close, Host Investor Call

Reuters
·
Aug 13

NexLiving Communities Declares Dividend of $0.01 Per Share for Quarter Ending Sept. 30, 2026

Reuters
·
Aug 13

Biomea Fusion Doses First Patient in OPAL Trial of Icovamenib Plus Semaglutide for Obesity

Reuters
·
Aug 13

Nutriband CEO Gareth Sheridan to Present at Georgia Life Sciences Summit CEO Spotlight

Reuters
·
Aug 13

Aebi Schmidt Q2 FY26 Net Income Returns to Profit at $10.47 Million; Adjusted Ebitda Rises 22% to $42.11 Million

Reuters
·
Aug 13